Janus Henderson Group PLC Sells 5,077 Shares of Solventum Co. (NYSE:SOLV)

Janus Henderson Group PLC lessened its holdings in shares of Solventum Co. (NYSE:SOLV) by 31.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,057 shares of the company’s stock after selling 5,077 shares during the quarter. Janus Henderson Group PLC’s holdings in Solventum were worth $771,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Deseret Mutual Benefit Administrators bought a new stake in Solventum during the second quarter worth about $25,000. Hollencrest Capital Management bought a new stake in Solventum in the 2nd quarter worth approximately $25,000. Richard W. Paul & Associates LLC purchased a new stake in Solventum in the second quarter worth approximately $26,000. Family Firm Inc. bought a new position in Solventum during the second quarter valued at approximately $26,000. Finally, Copeland Capital Management LLC purchased a new position in shares of Solventum during the third quarter worth approximately $26,000.

Wall Street Analysts Forecast Growth

SOLV has been the subject of a number of research reports. Wolfe Research began coverage on shares of Solventum in a research note on Thursday, September 26th. They issued a “peer perform” rating for the company. Piper Sandler raised their price objective on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Morgan Stanley boosted their target price on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Mizuho initiated coverage on Solventum in a report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 target price for the company. Finally, Stifel Nicolaus began coverage on Solventum in a research note on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price target on the stock. One research analyst has rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, Solventum presently has a consensus rating of “Hold” and a consensus price target of $68.29.

Solventum Stock Performance

NYSE SOLV opened at $69.56 on Friday. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $96.05. The stock has a 50 day simple moving average of $70.91 and a two-hundred day simple moving average of $63.22.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.